Retatrutide research advances with new clinical data

  Retatrutide has become an important subject in metabolic research as scientists investigate how a single experimental molecule can interact with three hormone receptors involved in energy balance and glucose regulation. Developed by Eli Lilly under the research code LY3437943,… Continue Reading →